Company Filing History:
Years Active: 2017-2019
Title: The Innovative Contributions of Caecilia Hendrina Theodora Chlon
Introduction
Caecilia Hendrina Theodora Chlon is a prominent inventor based in Eindhoven, Netherlands. She has made significant contributions to the field of fractional laser treatment, holding a total of 3 patents. Her work focuses on developing advanced treatment devices that enhance skin therapy through innovative laser technology.
Latest Patents
Chlon's latest patents include a "Treatment device for area and line fractional laser treatment." This invention provides a treatment device that comprises a treatment generator with a treatment laser and a laser scanning system. The system is designed to scan laser light across an emission window towards skin tissue from multiple locations, generating laser-based lesions within the skin. Additionally, her patent for a "Device for fractional laser-based treatment" features an emission window with predefined locations arranged in an elongated array. This device includes a motion sensor and a controller that determines the sequence of laser light emission based on the device's motion relative to the skin surface.
Career Highlights
Chlon is currently associated with Koninklijke Philips Corporation N.V., a leading company in health technology. Her role involves leveraging her expertise in laser technology to develop innovative solutions for skin treatment. Her contributions have been instrumental in advancing the capabilities of laser-based therapies.
Collaborations
Chlon has collaborated with notable colleagues, including Martin Jurna and Antonius Maarten Nuijs. These partnerships have fostered a collaborative environment that enhances the development of cutting-edge technologies in the field of laser treatment.
Conclusion
Caecilia Hendrina Theodora Chlon's innovative work in fractional laser treatment exemplifies her commitment to advancing medical technology. Her patents and collaborations reflect her significant impact on the industry, paving the way for future advancements in skin therapy.